1171 related articles for article (PubMed ID: 22172786)
1. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
[TBL] [Abstract][Full Text] [Related]
3. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
Laitinen I; Saraste A; Weidl E; Poethko T; Weber AW; Nekolla SG; Leppänen P; Ylä-Herttuala S; Hölzlwimmer G; Walch A; Esposito I; Wester HJ; Knuuti J; Schwaiger M
Circ Cardiovasc Imaging; 2009 Jul; 2(4):331-8. PubMed ID: 19808614
[TBL] [Abstract][Full Text] [Related]
5. Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with
Hellberg S; Liljenbäck H; Eskola O; Morisson-Iveson V; Morrison M; Trigg W; Saukko P; Ylä-Herttuala S; Knuuti J; Saraste A; Roivainen A
Contrast Media Mol Imaging; 2018; 2018():9186902. PubMed ID: 29950954
[TBL] [Abstract][Full Text] [Related]
6. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice.
Nakamura I; Hasegawa K; Wada Y; Hirase T; Node K; Watanabe Y
Biochem Biophys Res Commun; 2013 Mar; 433(1):47-51. PubMed ID: 23485468
[TBL] [Abstract][Full Text] [Related]
7. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice.
Silvola JM; Saraste A; Forsback S; Laine VJ; Saukko P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1011-5. PubMed ID: 21372297
[TBL] [Abstract][Full Text] [Related]
8. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
Front Immunol; 2022; 13():821423. PubMed ID: 35145523
[TBL] [Abstract][Full Text] [Related]
9. [18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.
Uotila S; Silvola JM; Saukko P; Nuutila P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J; Saraste A
J Ultrasound Med; 2014 Nov; 33(11):1941-8. PubMed ID: 25336481
[TBL] [Abstract][Full Text] [Related]
10. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
12. Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.
Ye YX; Calcagno C; Binderup T; Courties G; Keliher EJ; Wojtkiewicz GR; Iwamoto Y; Tang J; Pérez-Medina C; Mani V; Ishino S; Johnbeck CB; Knigge U; Fayad ZA; Libby P; Weissleder R; Tawakol A; Dubey S; Belanger AP; Di Carli MF; Swirski FK; Kjaer A; Mulder WJ; Nahrendorf M
Circ Res; 2015 Oct; 117(10):835-45. PubMed ID: 26394773
[TBL] [Abstract][Full Text] [Related]
13. Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A
Virta J; Hellberg S; Liljenbäck H; Ståhle M; Silvola JMU; Huusko J; Söderström M; Knuuti J; Nuutila P; Ylä-Herttuala S; Gomez MF; Roivainen A; Saraste A
Atherosclerosis; 2020 Jul; 305():64-72. PubMed ID: 32386751
[TBL] [Abstract][Full Text] [Related]
14. Determinants of FDG uptake in atherosclerosis.
Buettner C; Rudd JH; Fayad ZA
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1302-4. PubMed ID: 22172787
[No Abstract] [Full Text] [Related]
15. Amyloid-Targeting PET Tracer [
Hellberg S; Silvola JMU; Liljenbäck H; Kiugel M; Eskola O; Hakovirta H; Hörkkö S; Morisson-Iveson V; Hirani E; Saukko P; Ylä-Herttuala S; Knuuti J; Saraste A; Roivainen A
Molecules; 2019 Mar; 24(6):. PubMed ID: 30893771
[TBL] [Abstract][Full Text] [Related]
16. Uptake of 11C-choline in mouse atherosclerotic plaques.
Laitinen IE; Luoto P; Någren K; Marjamäki PM; Silvola JM; Hellberg S; Laine VJ; Ylä-Herttuala S; Knuuti J; Roivainen A
J Nucl Med; 2010 May; 51(5):798-802. PubMed ID: 20395326
[TBL] [Abstract][Full Text] [Related]
17. In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR
Blanco F; Heinonen SE; Gurzeler E; Berglund LM; Dutius Andersson AM; Kotova O; Jönsson-Rylander AC; Ylä-Herttuala S; Gomez MF
Diab Vasc Dis Res; 2018 Jul; 15(4):302-313. PubMed ID: 29499628
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques.
Rinne P; Hellberg S; Kiugel M; Virta J; Li XG; Käkelä M; Helariutta K; Luoto P; Liljenbäck H; Hakovirta H; Gardberg M; Airaksinen AJ; Knuuti J; Saraste A; Roivainen A
Mol Imaging Biol; 2016 Feb; 18(1):99-108. PubMed ID: 26122428
[TBL] [Abstract][Full Text] [Related]
19. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice.
Heinonen SE; Merentie M; Hedman M; Mäkinen PI; Loponen E; Kholová I; Bosch F; Laakso M; Ylä-Herttuala S
Cardiovasc Diabetol; 2011 Jun; 10():59. PubMed ID: 21718508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
